Lidofsky Steven D
Department of Medicine, University of Vermont, Given C-327, 89 Beaumont Avenue, Burlington, VT 05405, USA.
Curr Diab Rep. 2008 Feb;8(1):25-30. doi: 10.1007/s11892-008-0006-1.
Nonalcoholic fatty liver disease is an increasingly prevalent disorder that spans a range of conditions from hepatic steatosis to cirrhosis. It is commonly associated with obesity and diabetes, two components of the metabolic syndrome. Although hepatic steatosis may be reversible, disease progression appears to be triggered by overproduction of reactive oxygen species and mitochondrial injury in hepatocytes. Evolving treatments are focused on reversing insulin resistance, which underlies many of the metabolic derangements in this disease.
非酒精性脂肪性肝病是一种日益普遍的疾病,涵盖从肝脂肪变性到肝硬化的一系列病症。它通常与肥胖症和糖尿病相关,这两者是代谢综合征的组成部分。虽然肝脂肪变性可能是可逆的,但疾病进展似乎是由肝细胞中活性氧的过量产生和线粒体损伤引发的。不断发展的治疗方法集中在逆转胰岛素抵抗上,而胰岛素抵抗是该疾病许多代谢紊乱的基础。